{"id":46034,"date":"2022-07-11T18:02:03","date_gmt":"2022-07-11T16:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/"},"modified":"2022-07-11T18:02:03","modified_gmt":"2022-07-11T16:02:03","slug":"neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/","title":{"rendered":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing"},"content":{"rendered":"
\n

\nIndependent diagnostics laboratory can process 8,000 CDC-compliant tests per day to support consumer and healthcare demand<\/i>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–Amid rising concerns<\/a> about a lack of testing to stop the spread of the monkeypox virus, Neelyx Labs<\/a>, an independent diagnostics firm based in the Chicago area, announced they are now processing monkeypox PCR tests, with a capacity of 8,000 tests per day. Neelyx also delivers stat tests with a 1-hour turnaround using the XDiveTM<\/sup> ultrafast, real-time PCR instrument.\n<\/p>\n

<\/a><\/p>\n

\nHospitals, clinics, public health entities, and commercial laboratories can contact Neelyx Labs at (630) 214-3800<\/span> or info@neelyx.com<\/a>.<\/b>\n<\/p>\n

\nNeelyx Labs was established in 2020 to provide accurate, timely diagnosis of COVID-19 and its variants with RT-PCR testing and clinical sequencing. Since the emergence of monkeypox in the United States, Neelyx Labs has released a CDC-compliant PCR test for the virus that supports testing of dry swabs, swabs in transport media (wet swabs), lesions, and saliva.\n<\/p>\n

\n\u201cWe have high capacity that was proven during COVID, and we’ve duplicated those logistics for monkeypox testing,\u201d said Shyam Saladi, CEO and lead scientist at Neelyx Labs. \u201cHealthcare facilities and public health departments need flexibility and capacity to process thousands of specimens in aggregate or to focus on smaller subsets of high-priority cases. We support this with fast turnaround of PCR test results within 20 minutes through existing EMR portals.\u201d\n<\/p>\n

\nNeelyx Labs partners with OnsiteGene Inc.<\/a>, a San Diego-based biotechnology company supported by the National Institutes of Health\u2019s Rapid Acceleration of Diagnosis (RADx) program, to deploy the XDive PCR machine. XDive can complete 40 cycles of real-time PCR testing in as little as five minutes, while delivering fully automated sample-to-answer qPCR testing, nested PCR, or PCR with automated pre-amplification.\n<\/p>\n

\n\u201cXDive pushes the boundary of qPCR testing with order-of-magnitude improvements in run time and limit of detection,\u201d said Thomas Gong, president of OnsiteGene. \u201cThis is a breakthrough for many infectious disease applications that require fast turnaround and extreme sensitivity.\u201d\n<\/p>\n

\nNeelyx Labs follows all state and federal health guidelines and provides quick communication to public health officials to track and mitigate the spread of pathogens. For more information, visit www.neelyx.com<\/a>.\n<\/p>\n

\nAbout Neelyx Labs<\/b>\n<\/p>\n

\nNeelyx Labs is a next-generation, independent, diagnostics laboratory developing advanced rapid disease detection strategies for healthcare organizations, public health entities, commercial laboratories, and life sciences companies. The company has developed innovative clinical diagnostics using PCR and NGS technology, including one of the first COVID-19 variant tests, the fastest RT-PCR test for COVID-19, and innovative antigen tests for COVID-19. To learn more, visit www.neelyx.com<\/a>.\n<\/p>\n

\nAbout OnsiteGene<\/b>\n<\/p>\n

\nBased in San Diego, OnsiteGene, Inc. is a subsidiary of Star Array Pte Ltd., a bioengineering company that develops nucleic acid testing instruments, consumables, reagents, and test kits. OnsiteGene\u2019s vision is to make highly affordable automated nucleic acid testing available anywhere at any time for both laboratory testing and POCT applications. To learn more, visit www.onsitegene.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nBarbara Tabor, APR
\n
651.230.9192 \/ barbara@taborpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Independent diagnostics laboratory can process 8,000 CDC-compliant tests per day to support consumer and healthcare demand CHICAGO–(BUSINESS WIRE)–Amid rising concerns about a lack of testing to stop the spread of the monkeypox virus, Neelyx Labs, an independent diagnostics firm based in the Chicago area, announced they are now processing monkeypox PCR tests, with a capacity … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46034","6":"format-standard","7":"category-industry"},"yoast_head":"\nNeelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Independent diagnostics laboratory can process 8,000 CDC-compliant tests per day to support consumer and healthcare demand CHICAGO–(BUSINESS WIRE)–Amid rising concerns about a lack of testing to stop the spread of the monkeypox virus, Neelyx Labs, an independent diagnostics firm based in the Chicago area, announced they are now processing monkeypox PCR tests, with a capacity ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T16:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing\",\"datePublished\":\"2022-07-11T16:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/\"},\"wordCount\":496,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005512\\\/en\\\/1508581\\\/21\\\/Neelyx_Logo-public.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/\",\"name\":\"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005512\\\/en\\\/1508581\\\/21\\\/Neelyx_Logo-public.jpg\",\"datePublished\":\"2022-07-11T16:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005512\\\/en\\\/1508581\\\/21\\\/Neelyx_Logo-public.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220708005512\\\/en\\\/1508581\\\/21\\\/Neelyx_Logo-public.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/","og_locale":"en_US","og_type":"article","og_title":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend","og_description":"Independent diagnostics laboratory can process 8,000 CDC-compliant tests per day to support consumer and healthcare demand CHICAGO–(BUSINESS WIRE)–Amid rising concerns about a lack of testing to stop the spread of the monkeypox virus, Neelyx Labs, an independent diagnostics firm based in the Chicago area, announced they are now processing monkeypox PCR tests, with a capacity ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T16:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing","datePublished":"2022-07-11T16:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/"},"wordCount":496,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/","url":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/","name":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg","datePublished":"2022-07-11T16:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220708005512\/en\/1508581\/21\/Neelyx_Logo-public.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/neelyx-labs-announces-immediate-capacity-for-rapid-monkeypox-pcr-testing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Neelyx Labs announces immediate capacity for rapid monkeypox PCR testing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46034"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46034\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}